Skip to main content
OpenTrials
Completed

NCT Number: NCT01876576

The Impact of Diet Liberalization on Bowel Preparation for Colonoscopy

This study will evaluate the expansion of dietary options from clear liquids the entire day to a low reside breakfast and lunch for patients prior to undergoing bowel preparation with MoviPrep® and its effect on preparation quality for colonoscopy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colonic Diseases Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

About this study

This study will evaluate the expansion of dietary options from clear liquids the entire day to a low reside breakfast and lunch for patients prior to undergoing bowel preparation with MoviPrep® and its effect on preparation quality for colonoscopy. MoviPrep® is a commercially available 2 liter bowel purgative for use before colonoscopy in adults 18 years of age or older that is comprised of polyethylene glycol-electrolyte solution (PEG-ELS) plus sodium sulfate, sodium ascorbate, and ascorbic acid.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective outpatients > 18 yrs undergoing colonoscopy

Exclusion criteria

  • Unable or unwilling to give informed consent
  • Age < 18 years
  • Pregnant
  • Breast feeding
  • Gastroparesis - established or suspected
  • Pseudo-obstruction - established or suspected
  • Severe constipation (< 1 BM a week)
  • Bowel obstruction
  • Colon resection
  • Chronic nausea or vomiting
  • Known Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
  • PEG allergy
  • Significant psychiatric illness

Treatment and study plan

Clear liquids

Other

Clear liquids

Low residue breakfast and lunch

Other

Low residue

Primary outcomes

  1. Efficacy - Overall bowel cleansing based on Boston Bowel Preparation Scale score BBPS score of 2-3 for each segment AND total score

    Time frame: 1 day (At colonoscopy)

Secondary outcomes

  1. Efficacy - Individual colon segment cleansing Successful cleansing defined as BBPS score of 2 - 3 for a segment

    Time frame: 1 day (At colonoscopy)

Sponsors and collaborators

Lead sponsor

Thomas Jefferson University

Other

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Jun 12, 2013
Registry last updated
Jun 12, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.